Thailand has emerged as a growing hub for biotechnology research in Southeast Asia, with several companies developing therapies for neurological and neurodegenerative diseases. The country's strong pharmaceutical industry, combined with increasing investment in research and development, has fostered a growing ecosystem of biotech companies targeting Alzheimer's disease, Parkinson's disease, and related conditions.
Headquarters: Bangkok, Thailand
Website: https://www.bionet-asia.com
BioNet-Asia is a Thai biotech company focused on vaccine development and has expanded into neurological research. The company has developed partnerships with international research institutions for neuroscience programs.
Headquarters: Bangkok, Thailand
Sripa Pharmaceuticals is a Thai pharmaceutical company developing CNS drugs with a focus on neurodegenerative diseases. The company collaborates with universities in Bangkok for drug discovery research.
Headquarters: Bangkok, Thailand
Website: https://www.greaterpharma.com
Greater Pharma is a leading Thai pharmaceutical company with a growing focus on neurological disorders. The company has established research partnerships for developing treatments for Alzheimer's and Parkinson's diseases.
Headquarters: Bangkok, Thailand
Website: https://www.bbraun.co.th
While primarily a medical device company, B. Braun Thailand supports neurological treatments and has collaborated with local institutions on CNS therapy delivery systems.
Headquarters: Bangkok, Thailand
Website: https://www.gpo.or.th
The Government Pharmaceutical Organization (GPO) is a Thai state-owned pharmaceutical company that supports research in neurological diseases and partners with international organizations for drug development.
Headquarters: Bangkok, Thailand
Type: Biotechnology Company
Innobic is a Thai biotech company focused on innovative drug discovery, including programs targeting neurodegenerative diseases. The company leverages Thailand's biodiversity for natural product drug discovery.
Headquarters: Bangkok, Thailand
Website: https://www.vaxine.co.th
Vaxine is a Thai biotech company known for its immunology expertise. The company has expanded into neuroimmunology research, studying the role of immune modulation in neurodegenerative diseases.
Headquarters: Bangkok, Thailand
Type: Biotech Startup
Cellectrics is a Bangkok-based biotech startup developing cell therapy approaches for neurological disorders. The company focuses on stem cell treatments for neurodegenerative diseases.
Location: Bangkok, Thailand
Chulalongkorn University is Thailand's leading research university with strong neuroscience programs. The university collaborates with biotech companies on drug discovery for neurodegenerative diseases.
Location: Bangkok, Thailand
Mahidol University conducts significant research in neurology and neurodegenerative diseases. The university's faculty of medicine partners with industry on clinical research.
Location: Chiang Mai, Thailand
Chiang Mai University has research programs in natural products and neuroscience. The university collaborates with local companies on developing treatments from Thai medicinal plants.
Location: Bangkok, Thailand
Website: https://www.nst.or.th
The National Neuroscience Institute of Thailand is the premier research center for neurological disorders in Thailand. The institute conducts clinical research and partners with companies on therapeutic development.
Location: Bangkok, Thailand
Siriraj Hospital's Neuroscience Center is one of Thailand's leading clinical research facilities for neurological diseases. The center collaborates with pharmaceutical companies on clinical trials.
| Company | Focus Area | Stage |
|---|---|---|
| BioNet-Asia | Immunotherapy | Preclinical |
| Sripa Pharma | Small molecules | Research |
| Greater Pharma | CNS drugs | Discovery |
| Innobic | Natural products | Research |
| Vaxine | Neuroimmunology | Discovery |
Thailand's biotechnology sector is supported by: